Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress

Yaqin Chai,Xing Gu,HongJun Zhang,Xinting Xu,Lizhan Chen
DOI: https://doi.org/10.18632/aging.205468
2024-03-23
Aging
Abstract:Pulmonary arterial hypertension (PAH) is a severe pathophysiological syndrome resulting in heart failure, which is found to be induced by pulmonary vascular remodeling mediated by oxidative stress (OS) and inflammation. Phoenixin-20 (PNX-20) is a reproductive peptide first discovered in mice with potential suppressive properties against OS and inflammatory response. Our study will explore the possible therapeutic functions of PHN-20 against PAH for future clinical application. Rats were treated...
cell biology,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?